Is steroid resistance related to multidrug resistance-I (MDR-I) in rheumatoid arthritis?

International Immunopharmacology

Volumn 7, Issue 6, 2007, Pages 836-844

  Borowski, Luciana C ^a   Lopes, Rodrigo P ^a   Gonzalez, Tatiana P ^b   Dummer, Luana A ^b   Chies, José Artur B ^b   Silveira, Inês G ^a   Keisermann, Mauro ^a   Bauer, Moisés E ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

ABCB1 MDR1; Glucocorticoids; Lymphocyte proliferation; P glycoprotein; Polymorphisms; Rheumatoid arthritis

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123;

ADULT; AGED; ARTICLE; CELL ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; T LYMPHOCYTE;

ADULT; AGE FACTORS; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DEXAMETHASONE; DRUG RESISTANCE; FEMALE; GENE FREQUENCY; GLUCOCORTICOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; P-GLYCOPROTEIN; PHYTOHEMAGGLUTININS; POLYMORPHISM, GENETIC; RHODAMINE 123;

EID: 34247328169     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.02.004     Document Type: Article

References (44)

1. Smolen J.S., Aletaha D., and Machold K.P. Therapeutic strategies in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 19 (2005) 163-177
2. Wan Y., and Nordeen S.K. Identification of genes differentially regulated by glucocorticoids and progestins using a Cre/loxP-mediated retroviral promoter-trapping strategy. J Mol Endocrinol 28 (2002) 177-192
3. Schacke H., Docke W.D., and Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96 (2002) 23-43
4. Onda K., Rimbara E., Hirano T., Oka K., Abe H., Tahara K., et al. Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis. J Rheumatol 31 (2004) 464-469
5. De A., Blotta H.M., Mamoni R.L., Louzada P., Bertolo M.B., Foss N.T., et al. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis. J Rheumatol 29 (2002) 46-51
6. Heijnen C.J., and Kavelaars A. The importance of being receptive. J Neuroimmunol 100 (1999) 197-202
7. del Rincon I., O'Leary D.H., Haas R.W., and Escalante A. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 50 (2004) 3813-3822
8. Luz C., Dornelles F., Scapini E., Collaziol D., Preissler T., Cruz I., et al. Psychological and nutritional correlates of T-cell function in the healthy elderly. Stress 5 (2002) 80
9. Hirano T., Tsuboi N., Homma M., Oka K., Takekoshi T., Tahara K., et al. Comparative study of lymphocyte-suppressive potency between prednisolone and methylprednisolone in rheumatoid arthritis. Immunopharmacology 49 (2000) 411-417
10. Rohleder N., Wolf J.M., and Kirschbaum C. Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress 6 (2003) 207-222
11. van de Vrie W., Marquet R.L., Stoter G., De Bruijn E.A., and Eggermont A.M. In vivo model systems in P-glycoprotein-mediated multidrug resistance. Crit Rev Clin Lab Sci 35 (1998) 1-57
12. Diaz-Borjon A., Richaud-Patin Y., Alvarado de la Barrera C., Jakez-Ocampo J., Ruiz-Arguelles A., and Llorente L. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control. Joint Bone Spine 67 (2000) 40-48
13. Llorente L., Richaud-Patin Y., Diaz-Borjon A., Alvarado de la Barrera C., Jakez-Ocampo J., de la Fuente H., et al. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome. Joint Bone Spine 67 (2000) 30-39
14. Mickley L.A., Lee J.S., Weng Z., Zhan Z., Alvarez M., Wilson W., et al. Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood 91 (1998) 1749-1756
15. Hoffmeyer S., Burk O., von Richter O., Arnold H.P., Brockmoller J., Johne A., et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97 (2000) 3473-3478
16. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
17. Collaziol D., Preissler T., and Bauer M.E. Avaliação da proliferação linfocitária e sensibilidade a glicocorticóides por ensaios colorimétricos. Rev Med PUCRS 12 (2002) 226-231
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
19. Marie J.P., Huet S., Faussat A.M., Perrot J.Y., Chevillard S., Barbu V., et al. Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hopitaux de Paris. Leukemia 11 (1997) 1086-1094
20. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 (1991) 5444
21. Cascorbi I., Gerloff T., Johne A., Meisel C., Hoffmeyer S., Schwab M., et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 69 (2001) 169-174
22. Roberts R.L., Joyce P.R., Mulder R.T., Begg E.J., and Kennedy M.A. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. Pharmacogenomics J 2 (2002) 191-196
23. Schneider S, Roessli D, Excoffier L.: Arlequim: A software for population genetics data analysis In: UG Dept. of Anthropology, ed., 2 ed. Geneva: Genetics and Biometry Lab, 2000.
24. Rodrigues A.C., Rebecchi I.M., Bertolami M.C., Faludi A.A., Hirata M.H., and Hirata R.D. High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent. Braz J Med Biol Res 38 (2005) 1389-1397
25. Fiegenbaum M., da Silveira F.R., Van der Sand C.R., Van der Sand L.C., Ferreira M.E., Pires R.C., et al. The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment. Clin Pharmacol Ther 78 (2005) 551-558
26. Pawlik A., Baskiewicz-Masiuk M., Machalinski B., Kurzawski M., and Gawronska-Szklarz B. Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur J Pharmacol 528 (2005) 27-36
27. Doran M.F., Pond G.R., Crowson C.S., O'Fallon W.M., and Gabriel S.E. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46 (2002) 625-631
28. Taranto E., and Leech M. Expression and function of cell cycle proteins in rheumatoid arthritis synovial tissue. Histol Histopathol 21 (2006) 205-211
29. Mountz J.D., Wu J., Cheng J., and Zhou T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37 (1994) 1415-1420
30. Schlaghecke R., Beuscher D., Kornely E., and Specker C. Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance. Arthritis Rheum 37 (1994) 1127-1131
31. Percy J.S., Davis P., Russell A.S., and Brisson E. A longitudinal study of in vitro tests for lymphocyte function in rheumatoid arthritis. Ann Rheum Dis 37 (1978) 416-420
32. Kam J.C., Szefler S.J., Surs W., Sher E.R., and Leung D.Y. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 151 (1993) 3460-3466
33. Pariante C.M., Pearce B.D., Pisell T.L., Sanchez C.I., Po C., Su C., et al. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 140 (1999) 4359-4366
34. Luz C., Collaziol D., Preissler T., da Cruz I.M., Glock L., Bauer M.E., et al. Healthy aging is associated with unaltered production of immunoreactive growth hormone but impaired neuroimmunomodulation. Neuroimmunomodulation 13 (2006) 160-169
35. Bauer M.E. Stress, glucocorticoids and ageing of the immune system. Stress 8 (2005) 69-83
36. Bourgeois S., Gruol D.J., Newby R.F., and Rajah F.M. Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol Endocrinol 7 (1993) 840-851
37. Franchimont D., Martens H., Hagelstein M.T., Louis E., Dewe W., Chrousos G.P., et al. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 84 (1999) 2834-2839
38. Richaud-Patin Y., Vega-Boada F., Vidaller A., and Llorente L. Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients. Biomed Pharmacother 58 (2004) 320-324
39. Maillefert J.F., Maynadie M., Tebib J.G., Aho S., Walker P., Chatard C., et al. Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. Br J Rheumatol 35 (1996) 430-435
40. Yudoh K., Matsuno H., Nakazawa F., Yonezawa T., and Kimura T. Increased expression of multidrug resistance of P-glycoprotein on Th1 cells correlates with drug resistance in rheumatoid arthritis. Arthritis Rheum 42 (1999) 2014-2015
41. Pawlik A., Wrzesniewska J., Fiedorowicz-Fabrycy I., and Gawronska-Szklarz B. The MDR1 3435 polymorphism in patients with rheumatoid arthritis. Int J Clin Pharmacol Ther 42 (2004) 496-503
42. Farrell R.J., Murphy A., Long A., Donnelly S., Cherikuri A., O'Toole D., et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118 (2000) 279-288
43. Hitzl M., Drescher S., van der Kuip H., Schaffeler E., Fischer J., Schwab M., et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 11 (2001) 293-298
44. Johne A., Kopke K., Gerloff T., Mai I., Rietbrock S., Meisel C., et al. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin Pharmacol Ther 72 (2002) 584-594